Study guide

8.2 Scope, Standards, and Regulatory Practice

Certified Pediatric Hematology Oncology Nurse CPHON®

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy

2 Care Continuum

2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship

3 Leukemias and Lymphomas

3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas

4 CNS, Neuroblastoma, and Renal Tumors

4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors

5 Sarcomas and Other Solid Tumors

5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors

6 Hematologic Disorders

6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure

7 Pathophysiology, Genetics, and Diagnostics

7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis

8 Clinical Trials and Professional Performance

8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education

9 Chemotherapy and Biotherapy

9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy

10 Immunotherapy, Cellular Therapy, and Radiation

10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam

11 HSCT, Surgery, Transfusion, and Coagulation Therapy

11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy

12 Neurologic, Respiratory, and Cardiovascular Effects

12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects

13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects

13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects

14 Endocrine, Hematologic, Immunologic, and Sensory Effects

14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects

15 Pain, Sleep, Fatigue, and Mental Health

15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects

16 Supportive Care

16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care

17 Infectious and Gastrointestinal Emergencies

17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction

18 Metabolic Emergencies

18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome

19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome

19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)

20 Sickle Cell and Hemostasis Emergencies

20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed

21 Cardiopulmonary Emergencies

21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias

22 Neurologic and Infusion Emergencies

22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation

23 Family, Caregivers, and Social Integration

23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment

24 Development, Grief, Culture, and Community Resources

24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources

8.2 Scope, Standards, and Regulatory Practice

Key Takeaways Explain This Topic AI

CPHON is specialty registered-nurse practice under ANA and APHON standards; certification does not create independent prescriptive authority or allow unlicensed staff to check chemotherapy.

An unsafe chemotherapy order—wrong dose, outdated BSA, or wrong route—is not administered; vincristine is NEVER given intrathecally, and the nurse escalates through the chain of command.

USP <800> is the current US hazardous-drug handling framework: closed-system transfer devices as required, task-matched PPE, and spill kits. OSHA bloodborne-pathogen rules cover blood and body fluid and do not replace HD handling.

ONCC tests use generic drug names; radiation dosimeter badges are worn when occupational monitoring is assigned, not by every CPHON by default.

Keep an unencumbered RN license and report as the board requires; report suspected child abuse as a mandated reporter; share only the HIPAA minimum necessary with school nurses and camps.

Last updated: August 2026

A fellow writes an order for intrathecal vincristine on a 7-year-old with ALL who is due for a lumbar puncture and intravenous vincristine on the same day. The CPHON nurse is not a second prescriber and not a silent witness. Domain II.C.1, 4, and 5 tests scope of specialty RN practice , hazardous-drug and occupational safety , and regulatory duties that sit outside the protocol roadmap: license, mandatory reporting, and HIPAA when the school nurse or camp director calls.

CPHON is specialty RN practice, not independent prescribing

The American Nurses Association (ANA) scope-and-standards frame and APHON pediatric hematology/oncology nursing standards describe what a competent RN does: assess, educate, administer, advocate, and escalate. CPHON certification does not create advanced-practice authority. You do not independently prescribe chemotherapy, independently change a protocol dose, or function as a nurse practitioner because you passed ONCC's exam. You do independently verify that an order is complete, internally consistent, and safe to carry out, and you withhold administration when it is not.

Delegation follows the same line. Unlicensed assistive personnel may help with vital signs, hygiene, and stocking a spill kit. They do not independently check chemotherapy, access a central line for a vesicant, or teach a family that a fever of 38.0°C is an emergency as a substitute for RN assessment. If you delegate, you remain accountable for the decision to delegate and for the outcome. Document who did what. If it was not charted, the regulatory view is that it was not done.

Documentation is a legal record, not a courtesy to the next shift. Chart the independent double check, the actual dose and route given, the body-surface-area (BSA) or weight used, patient identifiers, and the family's questions. ONCC tests use generic drug names . The order, the pump library, the teaching sheet, and the exam item should say vincristine , methotrexate , doxorubicin , and ondansetron —not brand names from an older binder.

Unsafe chemo orders and the vincristine never-event

When a chemotherapy order is unsafe, the nurse's first action is not to administer . Classic traps:

Dose that does not match the protocol milligrams-per-square-meter or milligrams-per-kilogram after an independent BSA recalculation

  • BSA calculated on an outdated weight in a child who has gained or lost substantially
  • Route that does not match the drug's allowed routes

Vincristine is NEVER given intrathecally. Intrathecal vincristine is a fatal never-event. If an order, a label, or a verbal plan puts vincristine in the same syringe, the same tray, or the same thecal space as methotrexate, cytarabine, or hydrocortisone, you stop . You do not give a reduced IT vincristine dose. You do not mix vincristine with IT agents to save a puncture. You hold the drug, protect the child, and escalate through the chain of command —covering provider, attending, pharmacy, supervisor, and institutional event reporting—until the plan is corrected. Many centers keep vincristine in mini-bags, labeled for intravenous use only, and physically separate IT medications from vincristine. Those engineering controls do not replace the nurse's refusal to inject vincristine into the spine.

Chain of command is a patient-safety tool, not disloyalty. A culture of safety— Joint Commission expectations and Magnet professional-practice language—expects you to speak up, report near-misses, and refuse to normalize deviance. A fellow who says just this once is describing a never-event, not a teaching moment to comply.

Safety problem First nursing action Why it is not a gray area

Intrathecal vincristine ordered or labeled Do not administer; separate the drug; chain of command Fatal never-event

Dose or BSA does not match protocol after independent check Hold; recalculate; call prescriber and pharmacy Wrong dose is preventable harm

Unlicensed staff asked to check chemo Refuse the delegation; RN retains the check Chemo verification is RN practice

CPHON asked to rewrite a prescription Stay in RN scope; obtain a corrected order Certification is not APRN authority

USP <800>, OSHA, and radiation badges

USP <800> is the current United States compounding and handling framework for hazardous drugs (HDs) . It is not a nursing trivia chapter to recopy. What the CPHON nurse must operationalize:

Know which agents on your unit are on the HD list (most cytotoxic chemotherapy, and other drugs as the facility lists them).

Use closed-system transfer devices (CSTDs) when compounding or administering as your facility's HD procedures require.

Wear PPE that matches the task: chemo-tested gloves (commonly double gloving), a disposable gown that resists HD permeability, eye protection when splash is possible, and a respirator when the spill or formulation requires one—not a loose surgical mask for a powder spill.

Keep a spill kit where HDs are mixed or given. Restrict eating and drinking in HD handling areas.

Handle excreta from children recently treated with HDs per facility HD precautions.

Do not recopy containment-primary-engineering-control room diagrams from the USP chapter as exam memorization. Know the nursing behaviors: CSTD when required, PPE, spill kit, no food at the chemo pump, and stop-the-line if a gown is missing.

OSHA bloodborne-pathogen standards cover blood and body-fluid exposure: Standard Precautions, sharps safety, hepatitis B vaccination, and the exposure-control plan. They do not replace USP <800> for chemotherapy. A blood splash and a cyclophosphamide spill are different events with different kits.

Radiation safety badges (personal dosimeters) apply when your job includes occupational ionizing radiation—radiology or fluoroscopy support, radioisotope therapy such as I-131-MIBG, or brachytherapy care—as the radiation-safety officer assigns. Not every CPHON wears a badge. If you are assigned one, wear it as instructed and do not leave it on the dashboard of a car. Pregnant staff follow institutional radiation and HD policies; do not invent a universal exclusion from all oncology nursing.

License, abuse reporting, and HIPAA with schools and camps

ONCC eligibility requires a current, active, unencumbered RN license. Unencumbered means the license is not suspended, revoked, or restricted in a way that bars practice. If your license becomes encumbered, you have a duty to report as the board and employer require; you do not keep staffing a chemo chair. Colleague impairment or practice that endangers children is escalated, not gossiped.

Nurses are mandated reporters of suspected child abuse or neglect . You report to the designated child-protective agency. You do not wait for attending permission, a complete social-work note, or parental agreement. Suspicion, not courtroom proof, is the threshold. A toddler with repeated unexplained bruising who also has leukemia still needs a clinical differential; leukemia does not cancel the mandate if the history is inconsistent.

HIPAA still applies when a school nurse, camp director, or sports coach calls. Use the minimum necessary standard. The school nurse usually needs the fever rule, central-line or port precautions, activity limits, and who to call. The school nurse does not need the full genomic report, parental HIV status, or every research pharmacokinetic time point. Confirm identity, confirm the family has authorized school communication as required, and document what was shared. A camp form is a clinical communication, not an invitation to email the entire chart to a volunteer.

A 10-year-old returning to school after delayed intensification is a HIPAA case, not a publicity case. The school nurse gets the fever number and line precautions. The soccer coach does not get the protocol PDF. The camp director gets activity limits and who to call at night—not the parents' marital history.

The CPHON product on this domain is a nurse who can refuse an unsafe order, handle HDs under USP <800> without reciting the chapter, keep an unencumbered license, report suspected abuse, and tell the school only what the child needs to be safe.

Loading diagram... Unsafe chemotherapy order: stop, then escalate